3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Vascular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Ganglioneuroblastoma
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Interventions
Bevacizumab
11
durvalumab
10
Specimen Handling
10
atezolizumab
8
tremelimumab
7
lenvatinib
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
cabozantinib
4
X-Rays
4
Surgical Procedures, Operative
3
Sorafenib
3
Oxaliplatin
3
Immunotherapy
3
Fluorouracil
3
tislelizumab
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
donafenib
2
camrelizumab
2
apatinib
2
Leucovorin
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Carboplatin
2
Blood Specimen Collection
2
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Proton Therapy
×
30 days
×
Clear all
No trials found.